Physician

Kevin I Rosenberg, MD

According to 2025 Medicare claims, Kevin Rosenberg, MD (NPI: 1255560157) practices ophthalmology in the Syracuse, NY market, with the plurality of this provider's patient population coming from Onondaga, NY. This provider's primary affiliated billing organization is RETINA-VITREOUS SURGEONS OF CENTRAL NEW YORK, PC (NPI: 1124012737; TIN: 16-0993668) and primary practice location at 13088-6655.

Rosenberg's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,146 traditional Medicare patients, billed 28,521 HCPCS/CPT codes, and received $3,855,738 in Medicare payments. The top billing code was J0178 (Injection, aflibercept, 1 mg). Part D data shows 817 prescription claims across 240 beneficiaries totaling $21,486 in drug costs, led by Prednisolone Acetate (Prednisolone Acetate). Open Payments data shows 8 records totaling $6,326. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $473,494 to $3,855,738. Similarly, Part D prescription costs have risen steadily, from $3,195 to $21,486. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$2.0M$4.0M2015 Medicare payment: $473,494 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $2,208,713 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $2,373,512 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $2,528,322 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $2,717,539 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $2,899,434 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $3,345,771 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $3,572,940 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $4,006,908 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $3,855,738 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20154511,963$473,494
20168338,016$2,208,713
20179009,240$2,373,512
20188739,770$2,528,322
201992510,506$2,717,539
202084510,413$2,899,434
202199311,941$3,345,771
20221,08114,285$3,572,940
20231,12321,344$4,006,908
20241,14628,521$3,855,738

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$16K$32K2015 Drug cost: $3,195 (USD; Tot_Drug_Cst)2016 Drug cost: $16,274 (USD; Tot_Drug_Cst)2017 Drug cost: $14,522 (USD; Tot_Drug_Cst)2018 Drug cost: $22,953 (USD; Tot_Drug_Cst)2019 Drug cost: $16,132 (USD; Tot_Drug_Cst)2020 Drug cost: $21,179 (USD; Tot_Drug_Cst)2021 Drug cost: $31,683 (USD; Tot_Drug_Cst)2022 Drug cost: $24,197 (USD; Tot_Drug_Cst)2023 Drug cost: $21,297 (USD; Tot_Drug_Cst)2024 Drug cost: $21,486 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
201559124$3,195
2016130404$16,274
2017130425$14,522
2018148499$22,953
2019153525$16,132
2020148480$21,179
2021202690$31,683
2022212704$24,197
2023222691$21,297
2024240817$21,486

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
J0178Injection, aflibercept, 1 mg3573,740$654
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more311340$95
67028Injection of drug into eye4792,371$90
92014Established patient complete exam of visual system473564$88
92134Imaging of retina1,0083,127$30

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Prednisolone AcetatePrednisolone Acetate2348,670$8,969
Ketorolac TromethamineKetorolac Tromethamine1074,150$2,229
TobramycinTobramycin1253,287$680
Atropine SulfateAtropine Sulfate181,096$633
Timolol MaleateTimolol Maleate774,451$496

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.8$6,326Genentech USA, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Kevin I. Rosenberg, MD?

Tedicare shows public-source Medicare data for Kevin I. Rosenberg, MD (NPI 1255560157), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Kevin I. Rosenberg, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Kevin I. Rosenberg, MD?

Kevin I. Rosenberg, MD is linked to RETINA-VITREOUS SURGEONS OF CENTRAL NEW YORK, PC (billing NPI 1124012737) in the available physician profile data.

Does Kevin I. Rosenberg, MD have Open Payments data?

Kevin I. Rosenberg, MD has 8 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.